Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies

Journal Article · · PLoS Pathogens
 [1];  [2];  [3];  [2];  [3];  [2];  [4];  [5];  [1];  [6];  [4];  [7];  [2];  [1];  [8]
  1. Univ. of Texas, Austin, TX (United States); Geisel School of Medicine at Dartmouth, Hanover, NH (United States)
  2. Janssen Vaccines & Prevention, Leiden (The Netherlands)
  3. Janssen Pharmaceutical Companies of Johnson and Johnson, San Diego, CA (United States)
  4. Janssen Pharmaceutica NV, Beerse (Belgium)
  5. Janssen R&D US, San Diego, CA (United States)
  6. Janssen Pharmaceutical Companies of Johnson and Johnson, London (United Kingdom)
  7. Janssen Vaccines & Prevention B.V., Leiden (The Netherlands)
  8. National Inst. of Health (NIH), Bethesda, MD (United States)

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants and the elderly, and yet there remains no effective treatment or vaccine. The surface of the virion is decorated with the fusion glycoprotein (RSV F) and the attachment glycoprotein (RSV G), which binds to CX3CR1 on human airway epithelial cells to mediate viral attachment and subsequent infection. RSV G is a major target of the humoral immune response, and antibodies that target the central conserved region of G have been shown to neutralize both subtypes of RSV and to protect against severe RSV disease in animal models. However, the molecular underpinnings for antibody recognition of this region have remained unknown. Therefore, we isolated two human antibodies directed against the central conserved region of RSV G and demonstrated that they neutralize RSV infection of human bronchial epithelial cell cultures in the absence of complement. Moreover, the antibodies protected cotton rats from severe RSV disease. Both antibodies bound with high affinity to a secreted form of RSV G as well as to a peptide corresponding to the unglycosylated central conserved region. High-resolution crystal structures of each antibody in complex with the G peptide revealed two distinct conformational epitopes that require proper folding of the cystine noose located in the C-terminal part of the central conserved region. Comparison of these structures with the structure of fractalkine (CX3CL1) alone or in complex with a viral homolog of CX3CR1 (US28) suggests that RSV G would bind to CX3CR1 in a mode that is distinct from that of fractalkine. Collectively, these results build on recent studies demonstrating the importance of RSV G in antibody-mediated protection from severe RSV disease, and the structural information presented here should guide the development of new vaccines and antibody-based therapies for RSV.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22). Scientific User Facilities Division; NIH, Office of Research Infrastructure Programs
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1484790
Journal Information:
PLoS Pathogens, Journal Name: PLoS Pathogens Journal Issue: 3 Vol. 14; ISSN 1553-7374
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (84)

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus journal June 1986
Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation: Comparison of Alternate Methods for Adsorption of Anti-RSV Neutralizing Antibodies journal April 2005
Host Cell Effect upon Glycosylation and Antigenicity of Human Respiratory Syncytial Virus G Glycoprotein journal July 1996
Iduronic Acid-Containing Glycosaminoglycans on Target Cells Are Required for Efficient Respiratory Syncytial Virus Infection journal June 2000
Contribution of the Respiratory Syncytial Virus G Glycoprotein and Its Secreted and Membrane-Bound Forms to Virus Replication in Vitro and in Vivo journal October 2001
The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion journal July 1991
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development journal January 2017
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion journal November 1997
Solution Structure of the Immunodominant Region of Protein G of Bovine Respiratory Syncytial Virus , journal January 1996
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein journal August 2001
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor journal August 2017
The Burden of Respiratory Syncytial Virus Infection in Young Children journal February 2009
In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo journal March 2012
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. journal August 1987
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant journal December 1997
The Crystal Structure of the Chemokine Domain of Fractalkine Shows a Novel Quaternary Arrangement journal April 2000
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice journal August 2009
Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains journal May 2012
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure journal January 1985
Appearance of a Soluble Form of the G Protein of Respiratory Syncytial Virus in Fluids of Infected Cells journal June 1987
Demonstration that Glycoprotein G Is the Attachment Protein of Respiratory Syncytial Virus journal September 1987
Comparison of Antigenic Sites of Subtype-specific Respiratory Syncytial Virus Attachment Proteins journal November 1989
Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A journal April 1992
Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus journal June 1996
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells journal September 2015
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice journal March 2009
Coot model-building tools for molecular graphics journal November 2004
Overview of the CCP 4 suite and current developments journal March 2011
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM journal March 2011
Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor journal March 2015
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera journal October 2015
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail journal September 2017
Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. journal January 1986
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses journal October 2013
Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells journal March 2017
The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. journal January 1994
Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G journal August 1999
Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection journal November 2000
Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate journal November 2004
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective journal January 2014
Effects of Anti-G and Anti-F Antibodies on Airway Function after Respiratory Syncytial Virus Infection journal July 2014
The Respiratory Syncytial Virus G Protein Conserved Domain Induces a Persistent and Protective Antibody Response in Rodents journal March 2012
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner journal June 2015
X-Ray Diffraction data from RSV G peptide bound to Fab CB002.5, source of 6BLI structure dataset January 2018
X-Ray Diffraction data from RSV G peptide bound to Fab CB017.5, source of 6BLH structure dataset January 2018
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients journal October 2009
Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: Disuljides of respiratory syncytial virus G protein journal June 1997
Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina journal January 2021
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion journal November 1997
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study journal September 2017
Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G journal November 2002
Synthetic antibodies against BRIL as universal fiducial marks for single−particle cryoEM structure determination of membrane proteins journal March 2020
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation journal February 2021
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults journal April 2005
The Burden of Respiratory Syncytial Virus Infection in Young Children journal February 2009
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. journal June 1985
The Crystal Structure of the Chemokine Domain of Fractalkine Shows a Novel Quaternary Arrangement journal April 2000
Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion journal February 1991
Phaser crystallographic software journal July 2007
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Overview of the CCP 4 suite and current developments journal March 2011
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM journal March 2011
How good are my data and what is the resolution? journal June 2013
Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. journal January 1986
Structural Insights into the Human Metapneumovirus Glycoprotein Ectodomain journal July 2014
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses journal October 2013
Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice journal October 2009
Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells journal March 2017
Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. journal January 1991
The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. journal January 1994
Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G journal August 1999
Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection journal November 2000
Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate journal November 2004
Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates journal September 2005
Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium journal December 2004
Effects of Anti-G and Anti-F Antibodies on Airway Function after Respiratory Syncytial Virus Infection journal July 2014
Solution Structure of the Immunodominant Region of Protein G of Bovine Respiratory Syncytial Virus dataset January 2003
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures journal December 2015
Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium text January 2005
Overview of the CCP4 suite and current developments. text January 2011
Collaboration gets the most out of software journal September 2013

Cited By (7)

Respiratory syncytial virus entry and how to block it journal February 2019
Antibody Epitopes of Pneumovirus Fusion Proteins journal November 2019
Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein journal February 2019
Respiratory syncytial virus reduces STAT3 phosphorylation in human memory CD8 T cells stimulated with IL-21 journal November 2019
Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein journal January 2019
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains journal August 2018
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity journal March 2019